Sanghyun Peter Kim

9PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers.

S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst

|Dec 17, 2025
Selective expansion of T-cell receptor engineered T cells with increased stem-like phenotypes using neoantigen stimulation.

Sanghyun P Kim, Noam Levin, Youngseo Jo

|Jan 12, 2025
Utilization of primary tumor samples for cancer neoantigen discovery.

Vid Leko, Eric Groh, Shoshana T Levi

|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.

Noam Levin, Sanghyun P Kim, Charles A Marquardt

|Jun 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.

Sanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis

|Feb 03, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.

Frank J Lowery, Sri Krishna, Rami Yossef

Pageof 2

Frequent Collaborators

7 joint publications

Stephanie L Goff

6 joint publications

Paul Robbins

5 joint publications

Steven A Rosenberg

5 joint publications

Frank J Lowery